Status and phase
Conditions
Treatments
About
This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients of all races and ethnic groups are eligible for this trial.
Primary purpose
Allocation
Interventional model
Masking
601 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal